Home The Action Management Committee Matej Podbregar (SI)

Thu,23Feb2017

Prof. Matej Podbregar

Head of research program
Medical Faculty,
University of Ljubljana,
Slovenia

T: + 386 40 215 960
F: + 386 1 522  22 96
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Interests
H2S, shock, heart failure, pulmonary hypertesnion, critical ilness

Selected Recent Publications

  • Podbregar M, Lainscak M, Prelovsek O, Mars T. Cytokine response of cultured skeletal muscle cells stimulated with proinflammatory factors depends on differentiation stage. ScientificWorldJournal. 2013;2013:617170. doi:10.1155/2013/617170. Epub 2013 Feb 20. PubMed PMID: 23509435; PubMed Central PMCID: PMC3590685.
  • Pintaric TS, Hadzic A, Strbenc M, Podpecan O, Podbregar M, Cvetko E. Inflammatory response after injection of aqueous gel into subarachnoid space in
    piglets. Reg Anesth Pain Med. 2013 Mar-Apr;38(2):100-5. doi:10.1097/AAP.0b013e318284176a. PubMed PMID: 23386055.
  • Kovačić D, Glavnik N, Marinšek M, Zagožen P, Rovan K, Goslar T, Marš T,Podbregar M. Total plasma sulfide in congestive heart failure. J Card Fail. 2012 Jul;18(7):541-8. doi: 10.1016/j.cardfail.2012.04.011. Epub 2012 May 30. PubMedPMID: 22748487.
  • Goslar T, Marš T, Podbregar M. Total plasma sulfide as a marker of shock severity in nonsurgical adult patients. Shock. 2011 Oct;36(4):350-5. doi: 10.1097/SHK.0b013e31822bcfd0. PubMed PMID: 21897337.
  • Podbregar M. Thenar tissue oxygen saturation monitoring: noninvasive does not mean simple or accurate! Crit Care Med. 2012 Feb;40(2):712-3; author reply 713-4. doi: 10.1097/CCM.0b013e31823c8979. PubMed PMID: 22249076.



ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.